SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in DTIL — Precision Biosciences Inc

CIK 1446194 BALA CYNWYD, PA

Back to DTIL Full portfolio

Position in DTIL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$354,541

+$77,565 QoQ

Shares Held

64,462

-3.2% QoQ

Ownership

0.250%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#26

of 78 holders

Holding Since

Dec 2024

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in DTIL Over Time

Shares Held

Position Value (USD)

Derivatives in DTIL

reported options exposure · as of Mar 31, 2026

CallValue

$112,200

CallShares

20,400

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,159,899,084 across 353 Biotechnology names. DTIL ranks #255 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	898,951	$59,249,860
2	ALNY	Alnylam Pharmaceuticals, Inc.	174,268	$57,660,053
3	AGIO	Agios Pharmaceuticals, Inc.	1,344,953	$45,499,759
4	ABVX	Abivax S.A.	381,282	$42,455,750
5	BBIO	BridgeBio Pharma, Inc.	398,943	$29,625,507
6	INSM	INSMED Inc	173,630	$28,391,977
7	CRSP	CRISPR Therapeutics AG	593,406	$28,228,323
8	TERN	Terns Pharmaceuticals, Inc.	521,571	$27,497,223

All Filings in DTIL

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$112,200	20,400	-68.4%	Call	Other	2026-05-15
2026-03-31	$354,541	64,462	-3.2%	Shares	Other	2026-05-15
2025-12-31	$276,976	66,581	+141.8%	Shares	Other	2026-02-17
2024-12-31	$104,915	27,537	—	Shares	Other	2025-02-14
No filing history on record for this holder in this stock.